Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Completed · Phase 2
Conditions studied: Systemic Lupus Erythematosus, Lupus
In brief
The purpose of this study is to find the best way to prevent heart disease and stroke in people with lupus (systemic lupus erythematosis, or SLE). The study will evaluate the effectiveness of medication and a phone-based education program in controlling four risk factors for heart disease: smoking, obesity, high blood pressure, and inactivity. The study will also test the safety of commonly used heart medications in people with lupus.
Key facts
- Study ID
- NCT00054938
- Run by
- Brigham and Women's Hospital
- People needed
- 150
- Starts
- 2003-03-01
- Expected to finish
- 2005-12-01
- Last updated by the study team
- 2013-12-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- SLE as defined by the 1997 American College of Rheumatology criteria
- Acceptable methods of contraception
You may not qualify if…
- Participation in another experimental protocol for ASVD prevention
- Heavy alcohol consumption ( >= 3 drinks/day)
- Aspirin intolerance
- Certain medications, including coumadin, ACE inhibitors, potassium supplements, potassium sparing diuretics, cyclosporine, and lithium
- Peptic ulcer disease within 6 months prior to study entry
- History of an intracranial bleed or brain tumor
- Bleeding diathesis
- History of allergy or sensitivity to ACE inhibitors
- Uncontrolled high blood pressure (180 mm Hg/110 mm Hg)
- Creatinine > 2.0 mg/dl
- Renal artery stenosis
- Pregnant or breastfeeding
- Abnormal liver function tests (ALT > 2 X upper limit of normal)
- History of a muscle disease, or baseline CPK > 500U/L or 2 X upper limit of normal
Where it is running
- Brigham and Women's Hospital, RBB Brigham Arthritis Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.